NSABP FOUNDATION, INC.
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
- Conditions
- Breast Cancer
- First Posted Date
- 2011-08-19
- Last Posted Date
- 2015-05-08
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 1300
- Registration Number
- NCT01420185
Factors Influencing Decision-Making About the Use of Chemoprevention in Women at Increased Risk for Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2011-07-21
- Last Posted Date
- 2021-10-05
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 1023
- Registration Number
- NCT01399359
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32
- Conditions
- FatigueBreast CancerDepressionSleep Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-01-31
- Last Posted Date
- 2015-09-09
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 394
- Registration Number
- NCT01286233
- Locations
- 🇺🇸
Kaiser Permanente Medical Center - Anaheim/Orange County, Anaheim, California, United States
🇺🇸Kaiser Permanente - Deer Valley, Antioch, California, United States
🇺🇸Kaiser Permanente Medical Center - Baldwin Park, Baldwin Park, California, United States
Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery
- Conditions
- Colorectal CancerMetastatic Cancer
- First Posted Date
- 2010-08-26
- Last Posted Date
- 2013-05-10
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 9
- Registration Number
- NCT01189227
- Locations
- 🇺🇸
Kaiser Permanente - Deer Valley, Antioch, California, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States
🇺🇸Kaiser Permanente - Fremont, Fremont, California, United States
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
- Conditions
- Colorectal CancerPrecancerous Condition
- Interventions
- Other: placebo
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 406
- Registration Number
- NCT01011478
- Locations
- 🇺🇸
Regional Medical Center, Anniston, Alabama, United States
🇺🇸Providence Cancer Center at Providence Hospital, Mobile, Alabama, United States
🇺🇸Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2021-10-25
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 141
- Registration Number
- NCT01008150
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸Kaiser Permanente-San Diego, San Diego, California, United States
🇺🇸CCOP - Colorado Cancer Research Program, Inc., Denver, Colorado, United States
Study of Blood Samples From High-Risk Postmenopausal Women Who Received Treatment on Breast Cancer Prevention Clinical Trials NSABP-P-1 or NSABP-P-2
- Conditions
- Breast Cancer
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2015-05-08
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 1881
- Registration Number
- NCT00967239
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
- Conditions
- Breast CancerFatigue
- First Posted Date
- 2009-06-04
- Last Posted Date
- 2013-01-11
- Lead Sponsor
- NSABP Foundation Inc
- Registration Number
- NCT00914043
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2009-04-24
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 1613
- Registration Number
- NCT00887536
- Locations
- 🇺🇸
Birmingham Hematology and Oncology, Birmingham, Alabama, United States
🇺🇸Birmingham Hematology and Oncology - Brookwood, Birmingham, Alabama, United States
🇺🇸Birmingham Hematology and Oncology - Princeton, Birmingham, Alabama, United States
A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2008-12-05
- Last Posted Date
- 2021-10-06
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 20
- Registration Number
- NCT00803647
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸St. Joseph Hospital, Orange, California, United States
🇺🇸Kaiser Permanente-San Diego, San Diego, California, United States